Form 4 Tracker
ADARx Pharmaceuticals, Inc.
ADRX

11 insider filings · Latest: Sep 28, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 28, 2026Sep 30 9:29 PMErez ChimovitsDirector
Purchase
61,516$17.00$1.0M9,292,025(I)

View →

Sep 28, 2026Sep 30 9:25 PMCarl L GordonDirector, 10% Owner
Purchase
950,000$17.00$16.1M588,235(I)

View →

Sep 28, 2026Sep 30 9:23 PMORBIMED ADVISORS LLCDirector, 10% Owner
Purchase
950,000$17.00$16.1M588,235(I)

View →

Sep 28, 2026Sep 30 1:45 AMSR ONE CAPITAL MANAGEMENT, LLC10% Owner
Purchase
1,600,000$17.00$27.2M592,593(I)

View →

Sep 28, 2026Sep 30 1:43 AMSimeon GeorgeDirector, 10% Owner
Purchase
1,600,000$17.00$27.2M592,593(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 28, 2026Sep 30 9:29 PMErez ChimovitsDirector
Conversion
9,230,509—0(I)

View →

Sep 28, 2026Sep 30 9:25 PMCarl L GordonDirector, 10% Owner
Conversion
23,255,789—0(I)

View →

Sep 28, 2026Sep 30 9:23 PMORBIMED ADVISORS LLCDirector, 10% Owner
Conversion
23,255,789—0(I)

View →

Sep 28, 2026Sep 30 1:45 AMSR ONE CAPITAL MANAGEMENT, LLC10% Owner
Conversion
9,768,069—0(I)

View →

Sep 28, 2026Sep 30 1:43 AMSimeon GeorgeDirector, 10% Owner
Conversion
9,768,069—0(I)

View →

Sep 28, 2026Sep 30 1:38 AMLAV Biosciences Fund V, L.P.10% Owner
Conversion
13,894,789—0(I)

View →

Sep 24, 2026Sep 28 8:30 PMRui (Nmn) ZhuChief Technology Officer
Grant/Award
512,076$17.00512,076(D)

View →

Sep 24, 2026Sep 28 8:30 PMAlan Robert MacleodChief Scientific Officer
Grant/Award
170,692$17.00170,692(D)

View →

Sep 24, 2026Sep 28 8:30 PMRyan FiskCFO and CBO
Grant/Award
170,692$17.00170,692(D)

View →

Sep 24, 2026Sep 28 8:30 PMZhen LiDirector, President and CEO, 10% Owner
Grant/Award
1,024,152$17.001,024,152(D)

View →

Sep 24, 2026Sep 28 8:30 PMRobert William AcklesChief People Officer
Grant/Award
85,346$17.0085,346(D)

View →